ArticleAlzheimer's & dementia (New York, N. Y.)

Combination therapy targeting Alzheimer's disease risk factors is associated with a significant delay in Alzheimer's disease-related cognitive decline.

Yuan Shang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.